In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1852 News Items found
Charles Rudin and David Jones, leaders of the Druckenmiller Center
In the Clinic
MSK’s New Fiona and Stanley Druckenmiller Center for Lung Cancer Research Takes on Biggest Cancer Killer

The new Fiona and Stanley Druckenmiller Center for Lung Cancer Research brings together MSK physicians and scientists in an intensive, multidisciplinary effort against the number-one cause of death from cancer in the nation.
Illustration of DNA strands
In the Lab
Project GENIE Aims to Make Sense of Vast Amounts of Genomic Data

A multi-institutional effort led by MSK’s Charles Sawyers is seeking to interpret information about the genetic causes of cancer.
Microscopic image of spherical cluster of cells, most of them pink cells with a smaller number of blue ones.
Feature
Three Compelling Cancer Advances from 2015

MSK researchers moved cancer science ahead in 2015 with landmark discoveries that suggest new treatment strategies and shed light on how the disease progresses.
Consuming alcohol is dangerous when you have liver cancer or cirrhosis.
Ask the Expert
Should a Person with Liver Cancer Stop Drinking Alcohol?

Learn why medical oncologist Ghassan Abou-Alfa counsels his patients with liver cancer to stop drinking.
Researchers at MSK have devised a technique, based on machine learning, that can predict the DNA binding preferences of a protein called a transcription factor.
In the Lab
A Netflix-Inspired Approach to Understanding Biology and Medicine

Computers currently help us choose our favorite movies, books, and TV shows. Will personalized medicines be next?
Kenneth Offit
In the Clinic
Innovative Research Center Will Explore Hereditary Cancer Genes

MSK’s new Robert and Kate Niehaus Center for Inherited Cancer Genomics is using the latest in gene sequencing technologies to discover the inherited causes of cancer.
Robert J. Motzer
Q&A
Immunotherapy Pioneered at MSK Receives FDA Approval for Advanced Kidney Cancer

Thanks to the work of MSK’s Robert Motzer, people with advanced renal cell carcinoma (a type of kidney cancer) now have a new immunotherapy option available to them.
A scientist pictured in his lab
Announcement
MSK’s Lorenz Studer Named a 2015 MacArthur Fellow

The awards are given annually to people in an array of fields in the arts and sciences.
Hyperpolarized MRI
In the Clinic
Hyperpolarized MRI: A New Tool to Assess Treatment Response within Days

Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly.
people working in a lab
Feature
Sloan Kettering Institute Marks 70 Years of Changing Cancer

The research arm of Memorial Sloan Kettering was established to apply industrial techniques to the study of cancer.